ANTI-ACNE DAILY TREATMENT MOISTURIZER
La Roche Posay EFFACLAR DUO(+) is a moisturizer for acne-prone skin with reinforced anti-imperfection efficacy, to help rapidly clear existing spots, prevent their reappearance and limit the risk of marks.
HOW TO APPLY:
Take a hazelnut-sized amount of cream and warm it to facilitate its absorption. Gently massage into your forehead in light strokes your face.
Anti-imperfections, anti-marks and anti-recurrence.
EFFACLAR DUO(+) shows visible efficacy on imperfections after 12 hours*. This fast result has been demonstrated through clinical studies skin is significantly less red with a smoother texture.
Prevents pimple and offers an anti-recurrence.
Suitable for use on men, women, teen acne-prone skin and adult acne-prone skin.
*Compilation of studies conducted by La Roche-Posay
La Roche Posay EFFACLAR DUO +, moisturizer for oily skin has demonstrated efficacy on more than 13000 acne-prone subjects (clinical study on 32 subjects, use of Effaclar Duo+ for 2 months followed by 1 month without any product) :
- Reduces pimples and blackheads
- Prevents their reappearance
- Limits post-inflammatory hyperpigmentation marks (anti-red and brown marks)
Maintains results 1 month after stopping application*.
Excellent tolerance, even for sensitive skin for 90% of dermatologists and patients*.
*Consumer test, 49 women, 75men, application 2x/day during 4 weeks
Helps protect against the appearance of red or brown marks.
Avoid friction and scratching when cleansing or applying your skincare. Avoid touching skin as much as possible, keep nails short and avoid sun exposure, as it might worsen blemishes.
EFFACLAR is a complete range of anti-imperfection solutions for oily, acne-prone skin that targets all stages of the imperfection life cycle with high efficacy, while ensuring perfect tolerance.
IMPERFECTIONS AND MARKS
THE 3-STEP EFFACLAR ROUTINE – CLEANSE, CORRECT, PROTECT – HAS BEEN PROVEN EFFECTIVE ON SUBJECTS WITH ACNE-PRONE SKIN LIVING IN POLLUTED ENVIRONMENTS.*
*Quantitative study, Beijing/Shanghai, 2014, Total sample: n=600 ²DIM Sell-in YTD Sept 2015 ³INS/Kantar Health La Roche-Posay Barometers 2013